---
{"dg-publish":true,"permalink":"/USMLE/Psychiatry/Anxiety disorders/"}
---

# Epidemiology
---


# Etiology
---


# Classifications
---

| Disorder            | Defining Feature                                                                                                                                     | Key Differentiator                                                                                  | Dx & Tx                                                                                                                                       |
| :------------------ | :--------------------------------------------------------------------------------------------------------------------------------------------------- | :-------------------------------------------------------------------------------------------------- | :-------------------------------------------------------------------------------------------------------------------------------------------- |
| **Social Anxiety**  | Fear of **scrutiny/embarrassment** in social or performance situations.                                                                              | Fear is specific to social contexts; performance-only subtype exists.                               | ≥6 mo; **Tx:** SSRI/SNRI, CBT. Propranolol for performance type.                                                                              |
| **Panic Disorder**  | Recurrent, **<span style="background:rgba(240, 200, 0, 0.2)">discrete</span>, unexpected** panic attacks.                                            | **"Fear of the fear"**—persistent worry about having more attacks.                                  | <span style="background:rgba(240, 200, 0, 0.2)">≥1 mo</span> of worry/avoidance after attack; **Tx:** SSRI/SNRI, CBT. BZDs for acute attacks. |
| **Specific Phobia** | Marked, irrational fear of a **specific object or situation** (e.g., spiders, heights).                                                              | Fear is immediate & **predictable** upon exposure to the trigger.                                   | ≥6 mo; **Tx:** CBT with exposure is first-line.                                                                                               |
| **GAD**             | **Excessive, chronic, <span style="background:rgba(240, 200, 0, 0.2)">constant</span> worry** about **multiple** life domains (work, money, health). | Worry is "free-floating," not focused on one trigger; physical sx like **muscle tension, fatigue**. | <span style="background:rgba(240, 200, 0, 0.2)">≥6 mo</span>; **Tx:** SSRI/SNRI, Buspirone, CBT.                                              |
| **Agoraphobia**     | Fear of **≥2 situations** where **escape is difficult** (e.g., crowds, open spaces, public transport).                                               | Fear is about being **trapped** or unable to get help if anxiety occurs; leads to avoidance.        | ≥6 mo; **Tx:** SSRI/SNRI, CBT.                                                                                                                |

# Clinical features
---


# Diagnostics
---


# Treatment
---
## Psychotherapy
- <span style="background:rgba(240, 200, 0, 0.2)">CBT (preferred)</span>
## Pharmacotherapy
- First-line agents 
	- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Psychiatry/Antidepressants\|SSRIs]]</span>
	- SNRIs
- Alternative agents
	- [[USMLE/Psychiatry/Antidepressants\|Buspirone]]
	- [[USMLE/Psychiatry/Sedative-hypnotic drugs\|Benzodiazepines]] for short-term use only
	- TCAs, e.g., imipramine

>[!warning] 
>Long-term use of [[USMLE/Psychiatry/Sedative-hypnotic drugs\|benzodiazepines]] is associated with significant adverse effects (e.g., motor and cognitive impairment) and <span style="background:rgba(240, 200, 0, 0.2)">risk of dependence</span>.
